Arman A. Kahokehr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arman A. Kahokehr has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Andrew C. Peterson
Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
4 shared publicationsAaron C. Lentz
Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
1 shared publicationGeorge D. Webster
Division of Urology, Duke University Medical Center, Durham, North Carolina, and New York University School of Medicine (MAG), New York, New York
1 shared publication- Jack R. Walter
Division of Urology, Madigan Army Medical Center, Tacoma, WA
1 shared publication Jessica C. Lloyd
Division of Urology, Duke University Medical Center, Durham, NC
1 shared publication- John Patrick Selph
Department of Urology, University of Alabama at Birmingham, Birmingham, AL
1 shared publication
Latest Publications
- 1 August 2018
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 7 (4) , 580-592
Posterior urethral stenosis after prostate cancer treatment: contemporary options for definitive management
Posterior urethral stenosis (PUS) is an uncommon but challenging problem following prostate cancer therapy. A review of the recent literature on the prevalence of PUS and treatment modalities used in the last decade was performed. A summative narrative of current accepted techniques in management of PUS is presented, and supplement with our own experience and algorithms.
- 1 August 2018
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 7 (4) , 580-592
Posterior urethral stenosis after prostate cancer treatment: contemporary options for definitive management
Posterior urethral stenosis (PUS) is an uncommon but challenging problem following prostate cancer therapy. A review of the recent literature on the prevalence of PUS and treatment modalities used in the last decade was performed. A summative narrative of current accepted techniques in management of PUS is presented, and supplement with our own experience and algorithms.
- 15 July 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 200 (6) , 1302-1307
A Critical Analysis of Bulbar Urethroplasty Stricture Recurrence: Characteristics and Management
We evaluated the management of recurrent bulbar urethral stricture disease after urethroplasty at our institution. We performed an institution review board approved, retrospective case study of our urethroplasty database to collect stricture related and postoperative information with an emphasis on bulbar urethral stricture disease recurrence after urethroplasty between 1996 and 2012. Repair types included primary anastomotic, augmented anastomotic and onlay repair. Recurrence, which was defined as the need for intervention, was diagnosed with cystoscopy or retrograde urethrogram. We identified 437 men who underwent urethroplasty of bulbar urethral stricture disease as performed by 2 surgeons from January 1996 to December 2012. Of the men 395 had available followup data. Recurrence was identified in 25 men (6.3%), of whom all presented with symptoms, including a weak stream in 23, urinary tract infection in 1 and pyelonephritis in 1. Median time to recurrence was 10 months. Recurrence was initially treated endoscopically in 23 of 25 cases (92%), dilatation in 12 and visual urethrotomy in 11. In 5 patients (22%) further recurrence developed after endoscopic treatment, which was managed by repeat urethroplasty in 2, self-calibration only in 2 and visual urethrotomy with subsequent self-calibration in 1. We identified 2 distinct phenotypes of recurrent stricture, including type A—short focal recurrence, which may be salvaged with an endoscopic procedure, and type B—the long graft length type, which is less likely to be salvaged with endoscopy. Recurrence after urethroplasty is most likely to develop within the first 12 months. Type A short focal recurrence may be managed by a salvage endoscopic procedure, including dilation or visual urethrotomy. These data on the phenotype of recurrence may be useful for patient treatment.
- 15 July 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 200 (6) , 1302-1307
A Critical Analysis of Bulbar Urethroplasty Stricture Recurrence: Characteristics and Management
We evaluated the management of recurrent bulbar urethral stricture disease after urethroplasty at our institution. We performed an institution review board approved, retrospective case study of our urethroplasty database to collect stricture related and postoperative information with an emphasis on bulbar urethral stricture disease recurrence after urethroplasty between 1996 and 2012. Repair types included primary anastomotic, augmented anastomotic and onlay repair. Recurrence, which was defined as the need for intervention, was diagnosed with cystoscopy or retrograde urethrogram. We identified 437 men who underwent urethroplasty of bulbar urethral stricture disease as performed by 2 surgeons from January 1996 to December 2012. Of the men 395 had available followup data. Recurrence was identified in 25 men (6.3%), of whom all presented with symptoms, including a weak stream in 23, urinary tract infection in 1 and pyelonephritis in 1. Median time to recurrence was 10 months. Recurrence was initially treated endoscopically in 23 of 25 cases (92%), dilatation in 12 and visual urethrotomy in 11. In 5 patients (22%) further recurrence developed after endoscopic treatment, which was managed by repeat urethroplasty in 2, self-calibration only in 2 and visual urethrotomy with subsequent self-calibration in 1. We identified 2 distinct phenotypes of recurrent stricture, including type A—short focal recurrence, which may be salvaged with an endoscopic procedure, and type B—the long graft length type, which is less likely to be salvaged with endoscopy. Recurrence after urethroplasty is most likely to develop within the first 12 months. Type A short focal recurrence may be managed by a salvage endoscopic procedure, including dilation or visual urethrotomy. These data on the phenotype of recurrence may be useful for patient treatment.